Exploration of the molecular mechanisms and drug target screening for neurological genetic and degenerative diseases using iPSCs and 3D organoids.
Click:
Focusing on ALS and PolyQ diseases, utilizing patient-derived iPSCs and organoid models, to investigate the molecular pathological mechanisms of the diseases and screen for effective therapeutic targets.
